AnaptysBio Inc is a biotechnology company. The Company is engaged in developing first-in-class antibody product candidates focused on unmet medical needs in inflammation and immuno-oncology. Its product include ANB020 and ANB019.
Stock Price Prediction
Update at 5:00pm EST
11.344 - 11.414
11.414 - 11.464
10.764 - 10.851
10.851 - 10.913
10.925 - 11.053
11.053 - 11.144
as of: 2019-11-19 4:24:13 PM
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.ANAB has closed above bottom band by 27.1%. Bollinger Bands are 324.9% wider than normal. The large width of the bands suggest high volatility as compared to ANAB's normal range. The bands have been in this wide range for 7 bars. This is a sign that the current trend might continue.
2019-11-08 AnaptysBio Earnings: Why ANAB Stock Is Plunging 72% AnaptysBio (ANAB) earnings for the antibody development company's third quarter of 2019 have ANAB stock taking a dive on Friday.
2019-11-08 AnaptysBio (NASDAQ:ANAB) Stock Rating Lowered by Wedbush AnaptysBio (NASDAQ:ANAB) was downgraded by equities researchers at Wedbush from an “outperform” rating to a “neutral” rating in a research note issued to investors on Friday, The Fly reports. Other analysts have also issued research reports about the company. Stifel Nicolaus restated a “hold” rating on shares of AnaptysBio in a report on Monday, September […]
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.